No takes yet. Share an insight, caveat, or question.
Clinical review demonstrates diagnostic biomarker utility in disseminated intravascular coagulopathy, suggesting antithrombin replacement improves severe systemic outcomes.
Senno et al. (2000) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: